- For referrals to preclinical and clinical consultants within the CPDD membership regarding the abuse assessment and abuse liability of drugs contact the chair of the Committee on the Abuse Liability of Drugs, Patrick M. Beardsley, Ph.D. (email:patrick.beardsley@vcuhealth.
org; tel: 804 828-5185) - Regulatory Control of Drugs with Abuse Potential and Abuse Liability Evaluation Resources
a. FDA Draft – Guidance for Industry – Assessment of Abuse Potential January 27, 2010
b. Federal Register – FDA Draft Guidance January 2010
c. CPDD Comments on FDA Guidance March 22, 2010 - Single Convention On Narcotic Drugs 1961
- Convention On Psychotropic Substances 1971
- United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances 1988
- Controlled Substances Act 1970
- Controlled Substances Act 1970 + Amendments
- Scholten_International Regulatory Environment for the Abuse Liability Evaluation
- Canada – Clinical Assessment of Abuse Liability for Drugs with Central Nervous System Activity
- EMEA Guidelines On The Non-Clinical Investigation Of The Dependence Potential Of Medicinal Products
- Russia_Guidelines for Abuse Liability Evaluation
